age, raises variety of considerations. initial, the cutoffs are based upon the unfounded assumption that a fixed proportion of kids, even for the age of 2 years, is overweight or obese. second, they will are derived from cross-sectional information, and thus not predictive. though centile charts drawn from cross-sectional information provide the impression of clinical continuity, they will don't describe the tracking of individual kids. In reality, bmi tracks relatively poorly from early childhood to adulthood. hesketh found that 20% of ‘obese’ 5–10 year olds had spontaneously resolved to firmly the most appropriate weight at intervals 3 years. 2 tracking obviously improves the nearer the kid gets to firmly adult standing, 3, 4 other then most adults, not less than to firmly date, have not been obese as young kids. 5–8 third, and the majority importantly, the who adult cutoffs were chosen upon the basis of established health risk. 9 the children’s were not, and they will are arbitrary. within the whole context of effective kid health surveillance, the clinician desires to firmly know whether or not cutoffs throughout the centile chart reliably establish children at risk of current or future metabolic disturbance. weight excess is undoubtedly related to insulin resistance and metabolic disturbance in adults, 10 other then the relationship is not a powerful one and also the corresponding associations in children are less clear still. as cole has got wind, a centile cutoff wherein the health risk of obesity starts to firmly rise can't be identified with any precision in kids. 1 clinical validity ( association of bmi with current or future morbidity/ mortality ) is a lot of necessary to firmly establish than measurement validity ( correlation with unwanted fat ).
The bogalusa study is widely cited as proof for a relationship between childhood overweight and cardiovascular risk. in spite of this, the associations between children’s bmi and metabolic disturbance are weak. chance, which improves with increasing numbers, is wrongly used throughout to firmly argue for strength of association. correlation, when low, can stay thus, in spite of this massive the numbers or tiny the p-value. on your 2000 5–10-year-olds within the bogalusa study, most had no risk factors in any respect. 11 merely eight had more often four elements on your metabolic syndrome, and every one of them fell directly into class of ‘overweight’ ( bmi495th centile ). in spite of this, 40% of these overweight had no risk factors at all, whereas 22% of these deemed ‘normal’ had some. currently being a screening tool, bmi discriminated poorly between those with and while not risk. it should give valuable information for the epidemiologist, other then very little regarding the paediatrician. what then on your relationship between bmi standing in childhood and metabolic disturbance in adulthood, the outcome live of principle concern ? typically benchmarked currently being a longitudinal cohort study, bogalusa is really a series of seven cross-sectional studies within which merely 55% of the participants seem more often once. this is often vital because cross-sectional information can not give particulars on tracking, merely associations among a population on a given time. the earlybird study was came upon in 2000 currently being a longitudinal study of growth and maturation, with metabolic health as the outcome live. it involves three hundredunited nations monitors. the unarme youngsters and their folks and actually has obtained fasting blood samples annually coming from the age of 5 years, so that you can monitor the emergence of insulin resistance ( homa-ir12 ) and its metabolic impact. 13 whereas the parents’ information show a transparent relationship between bmi and homa-ir, explaining 28% ( 41% ) of the variance in insulin resistance within the fathers ( mothers ) ( figure 1 ), the corresponding association in his or her children aged 5 years is weak, at best explaining 6%. it therefore looks unlikely, given the restricted relationship between prepubertal and adult bmi, that a bmi at 5 years can usefully establish those presently at metabolic risk or doubtless to actually become thus later on.
when earlybird youngsters are classified per their respective bmi cutoffs as ‘normal’, ‘overweight’ and ‘obese’, there's a regular stepwise increase in mean insulin resistance per weight class ( figure 2 ). in spite of this, categorisation of the kind says nothing concerning the predictive sensitivity or specificity of bmi. mean insulin resistance clearly differs between youngsters classified per iotf criteria, other then the performance of bmi class currently being a screening tool for individual risk is poor. triglycerides, a marker for metabolic disturbance, 14 fare no higher ( information not shown ). bmi may be a relatively blunt tool within the early detection of metabolic risk. modification in bmi, eventually, would seem to remain a additional useful marker compared to a only live at, by way of example, faculty entry. 15 so the long-term importance of obesity in childhood remains unclear. 16, 17 we could notice no proof to compliment the categorisation of terribly young kids by bmi into those at risk of metabolic disturbance. it is vital to seem beyond p-values, that sample size dependent, to actually contemplate effect size. bmi, at this age, won't justify a clinically useful proportion as to the variance in either insulin resistance or triglycerides. bmi is, though, merely a proxy for adiposity, the principal issue driving insulin resistance. 18 as others have pointed out, whereas bmi continues to actually serve well for several purposes, the time might currently be right to maneuver towards standards of adiposity primarily based on direct measures of adipose tissue. 19 we might go additional still. as nonetheless, we grasp very little relating to the tracking of any metabolic risk issue however, just like a direct live of metabolic disturbance, insulin resistance, or its metabolic correlates, might ultimately prove the foremost useful live of all in the identification as to the kid at risk. understanding the pathogenesis of disease from its earliest development is crucial to actually its prevention. just like a prospective study, earlybird can always add to actually that understanding. in conclusion, the use of any bmi thresholds for overweight and obesity ought to be used with care in terribly young kids. just like a marker for abnormal metabolic indices, bmi won't meet screening criteria. whereas giving false reassurance to actually a few, others could be unnecessarily stigmatised. 8 classifying persons as ‘normal’ or otherwise, according to actually their bmi, elevates the live a screening tool to actually a diagnostic criterion. 20 till we are able to specify categories of risk related to childhood adiposity, populationbased approaches to actually the prevention of obesity are doubtless to actually be additional effective than approaches targeted at fat kids. 7 the use of iotf charts ought to be restricted to actually the aim for that these were devised – to actually assess population trends and to create international comparisons. acknowledgements we are grateful to actually diabetes uk, roche pharmaceuticals, the henry smith foundation, the earlybird diabetes trust, the diabetes foundation and of course the kid growth foundation. others who haven generously supported earlybird include abbott laboratories, gsk, astra-zeneca, ipsen, unilever analysis, the beatrice laing foundation, the london law trust and eli lilly.
References
1 Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a
standard definition for child overweight and obesity worldwide:
international survey. BMJ 2000; 320: 1240–1243.
2 Hesketh K, Wake M, Waters E, Carlin J, Crawford D. Stability of
body mass index in Australian children; a prospective cohort
study across the middle childhood years. Public Health Nutr 2004;
7: 303–309.
3 Serdula MK, Ivery D, Coates RJ, Freedman DS, Williamson DF,
Byers T. Do obese children become obese adults? A review of the
literature. Prev Med 1993; 22: 167–177.
4 Guo SS, Roche AF, Chumlea WC, Gardner JD, Siervogel RM. The
predictive value of childhood body mass index values for
overweight at age 35y. Am J Clin Nutr 1994; 59: 810–819.
5 Williams S. Overweight at age 21: the association with body mass
index in childhood and adolescence and parents’ body mass
index. A cohort study of New Zealanders born in 1972–1973. Int J
Obes Relat Metab Disord 2001; 25: 158–163.
6 Braddon FE, Rodgers B, Wadsworth ME, Davies JM. Onset of
obesity in a 36 year birth cohort study. BMJ 1986; 293: 299–303.
7 Power C, Lake JK, Cole TJ. Body mass index and height from
childhood to adulthood in the 1958 British born cohort. Am J
Clin Nutr 1997; 66: 1094–1101.
8 Charney E. Childhood obesity: the measurable and the meaningful.
J Pediatr 1998; 132: 193–195.
9 World Health Organization Consultation on Obesity. Preventing
and managing the global epidemic: report of a WHO Consultation
on Obesity, Geneva, 3–5 June 1997. Geneva, Switzerland:
World Health Organization 1998; 1–276.
10 Han TS, Williams K, Sattar N, Hunt KJ, Lean ME, Haffner SM.
Analysis of obesity and hyperinsulinemia in the development of
metabolic syndrome: San Antonio Heart Study. Obes Res 2002; 10:
923–931.
11 Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The
relation of overweight to cardiovascular risk factors among
children and adolescents: the Bogalusa Heart Study. Pediatrics
1999; 103: 1175–1182.
12 Gungor N, Saad R, Janosky J, Arslanian S. Validation of surrogate
estimates of insulin sensitivity and insulin secretion in children
and adolescents. J Pediatr 2004; 144: 47–55.
13 Voss LD, Kirkby J, Metcalf BS, Jeffery AN, O’Riordan C, Murphy
MJ et al. Preventable factors in childhood that lead to insulin
resistance, diabetes and the metabolic syndrome: the EarlyBird
Diabetes Study (1). J Pediatr Endocrinol and Metab 2003; 16:
1211–1224.
14 Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G
et al. Prevalence of insulin resistance in metabolic disorders: the
Bruneck Study. Diabetes 1998; 47: 1643–1649.
15 Sinaiko AR, Donahue RP, Jacobs DR, Prineas RJ. Relation of
weight and increase in weight during childhood and adolescence
to body size, blood pressure, fasting insulin, and lipids in young
adults. Circulation 1999; 99: 1471–1476.
16 Power C, Lake JK, Cole TJ. Measurement and long-term health
risks of child and adolescent fatness. Int J Obes Relat Metab Disord
1997; 21: 507–526.
17 Viner RM, Cole TJ. Adult socio-economic, educational,
social, and psychological outcomes of childhood obesity:
a national birth cohort study. BMJ 2005; 330: 1354. Epub 2005
May 17.
18 Grundy SM. Hypertriglyceridemia, insulin resistance,
and the metabolic syndrome. Am J Cardiol 1999; 83 (9B):
25F–29F.
19 Prentice AM, Jebb SA. Beyond body mass index. Obes Rev 2001; 2:
141–147.
20 Steelman M, Weiss WP, Maese F, Lechin M, Yanovski SZ, Yanovski
JA. Pharmacotherapy for obesity. N Engl J Med 2002; 346:
2092–2093.
Keywords: IOTF cutoffs; childhood overweight and obesity; BMI; screening for metabolic risk
0 komentar:
Posting Komentar